Robert G. Shawah

Insider Reports History

Entity
Individual
Location
C/O Dipexium Pharmaceuticals, Llc, 74 Broad Street, New York, NY
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: Robert G. Shawah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert G. Shawah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Acurx Pharmaceuticals, Inc. Chief Financial Officer Stock Option 145K Feb 23, 2024 Direct

Insider Reports Filed by Robert G. Shawah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACXP Acurx Pharmaceuticals, Inc. Feb 23, 2024 1 $0 4 Apr 3, 2024 Chief Financial Officer
ACXP Acurx Pharmaceuticals, Inc. Feb 13, 2023 1 $0 4 Feb 24, 2023 Chief Financial Officer
ACXP Acurx Pharmaceuticals, Inc. Jun 29, 2021 2 $0 4 Jul 6, 2021 Chief Financial Officer
ACXP Acurx Pharmaceuticals, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 Chief Financial Officer